Fecal calprotectin is a reliable marker of endoscopic response to vedolizumab therapy: A simple algorithm for clinical practice

BACKGROUND AND AIM: The association of fecal calprotectin (FC) and endoscopic response in inflammatory bowel disease patients during vedolizumab (VDZ) treatment is largely unknown. The aim of this study is to assess the diagnostic value of FC to predict endoscopic response. METHODS: Patients with ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Pauwels, Renske Wilhelmina Maria, de Vries, Annemarie Charlotte, van der Woude, Christien Janneke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687080/
https://www.ncbi.nlm.nih.gov/pubmed/32291796
http://dx.doi.org/10.1111/jgh.15063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687080/
https://www.ncbi.nlm.nih.gov/pubmed/32291796
http://dx.doi.org/10.1111/jgh.15063

Ejemplares similares